Heng Huang Pharmaceutical Furfurylamine Nib has been approved to enter the European market, which is the first original new drug from Shanghai to enter the US and European markets.

Gate.io 2023 November 6, Shanghai’s first successful entry into the US and European markets, becoming the second global head market success in just 7 months after the US market, with the approval of the European Commission on June 22, the anti-tumor new drug Furuta Nini developed by Hutchison Pharmaceuticals (00013.HK) was approved for the treatment of metastatic colorectal cancer. Therefore, Furuta Nini has become the first original new drug to successfully enter the two benchmark markets of the United States and Europe.